Participants 90 94 3
acne
Participants 417 519 6
This was an investigator-blinded, randomized, parallel group trial conducted at 3 centers in Thailand.
Participants 520 701 7
Female subjects 18-45 years old were assigned to one or the other OCs and evaluated for efficacy and safety parameters at the baseline visit and after 1, 3 and 6 months of treatment
Participants 717 834 6
201 randomized subjects, data from 93 subjects in the EE/NGM group and 95 subjects in the EE/DSG group were analyzed.
